Drug recall · May 29, 2019
Promacta recall
Why: Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
- Lots / codes
Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.
- Quantity
- 792 cartons
- Company
- Novartis Pharmaceuticals Corp., East Hanover, NJ
- Distribution
- Nationwide with in the United States
- Initiated
- May 11, 2019 · Voluntary: Firm initiated
- Classified
- May 29, 2019
- Reported
- May 29, 2019
- Ended
- November 28, 2023
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eltrombopag
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.